Mets’ Jorge Polanco feels better after injection, but return date unclear
New York Times
Last updated: May 15, 2026
New York Mets first baseman/designated hitter Jorge Polanco received a platelet-rich plasma (PRP) injection about a month ago to aid his recovery from an Achilles injury. This treatment is part of his ongoing rehabilitation process.
- Jorge Polanco, a key player for the New York Mets, underwent a platelet-rich plasma (PRP) injection approximately one month prior to the article's writing. The purpose of this medical procedure was to accelerate and support his recovery from an Achilles injury. Polanco has been placed on the 10-day injured list, with the team stating he is dealing with a hamstring issue. However, the PRP injection specifically targets his Achilles tendon. This treatment involves drawing blood, processing it to concentrate the platelets, and then reinjecting this concentrated plasma into the injured area. Platelets are rich in growth factors that are believed to promote healing and reduce inflammation, making it a common therapeutic option for soft tissue injuries like Achilles tendinopathy. The Mets are hopeful that this intervention will allow him to return to the field sooner rather than later, though no specific timeline for his return has been provided. This injury and treatment regimen impact the Mets' offensive lineup.
